HumiraMeSH concept

https://www.has-sante.fr/jcms/p_3426145/fr/humira-adalimumab-psoriasis-en-plaques-chez-l-enfant-et-adolescent
2023
France
evaluation of the transparency committee
Adalimumab
adalimumab
Adolescent
adolescence
Psoriasis
Adolescent
child
Child
psoriasis vulgaris
Child
psoriasis
Child
Child
bone plates
humira
child, nos
adolescent

---
https://www.has-sante.fr/jcms/p_3143614/fr/humira
2020
false
false
false
France
insurance, health, reimbursement
evaluation of the transparency committee
Adalimumab
humira
Adalimumab

---
https://www.has-sante.fr/portail/jcms/c_2834708/fr/humira
2018
false
false
false
false
France
French
evaluation of the transparency committee
humira
Adalimumab

---
https://www.has-sante.fr/portail/jcms/c_2869247/fr/humira
2018
false
false
false
false
France
French
evaluation of the transparency committee
Adalimumab
adalimumab
adult
arthritis, rheumatoid
methotrexate
drug therapy, combination
treatment outcome
humira
Adalimumab

---
https://www.has-sante.fr/portail/jcms/c_2865442/fr/humira
2018
false
false
false
false
France
French
evaluation of the transparency committee
hidradenitis suppurativa
adolescent
insurance, health, reimbursement
humira
Adalimumab

---
http://www.has-sante.fr/portail/jcms/c_2745260/fr/humira
2017
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
Adalimumab
treatment outcome
adult
adalimumab
tumor necrosis factor-alpha
injections, subcutaneous
uveitis, intermediate
uveitis, posterior
panuveitis
insurance, health, reimbursement
immunosuppressive agents
immunosuppressive agents
humira
Adalimumab
Tumor Necrosis Factor Inhibitors

---
http://www.has-sante.fr/portail/jcms/c_2625986/fr/humira
2016
false
false
false
false
France
French
evaluation of the transparency committee
humira
Adalimumab
antibodies, monoclonal, humanized

---
http://www.has-sante.fr/portail/jcms/c_2671785/fr/humira
2016
false
false
false
France
French
evaluation of the transparency committee
humira
Adalimumab

---